Skip to Content
Merck

Y0001194

Resveratrol

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

3,4′,5-Trihydroxy-trans-stilbene, 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol

Slide 1 of 1
Sign In to View Organizational & Contract Pricing.

Select a Size

25 MG

€141.00

€141.00

Please contact Customer Service for Availability
Request a Bulk Order

About This Item

Empirical Formula (Hill Notation):
C14H12O3
CAS Number:
501-36-0
Molecular Weight:
228.24
NACRES:
NA.24
PubChem Substance ID:
329831299
UNSPSC Code:
41116107
MDL number:
MFCD00133799

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Resveratrol, European Pharmacopoeia (EP) Reference Standard

InChI

1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+

SMILES string

Oc1ccc(cc1)\C=C\c2cc(O)cc(O)c2

InChI key

LUKBXSAWLPMMSZ-OWOJBTEDSA-N

grade

pharmaceutical primary standard

API family

resveratrol

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

−20°C

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
34092PHL8953976511
Resveratrol European Pharmacopoeia (EP) Reference Standard

Y0001194

Resveratrol

Resveratrol analytical standard

Supelco

34092

Resveratrol

trans-Resveratrol phyproof® Reference Substance

PHL89539

trans-Resveratrol

Resveratrol certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

Supelco

76511

Resveratrol

manufacturer/tradename

EDQM

manufacturer/tradename

-

manufacturer/tradename

PhytoLab

manufacturer/tradename

Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

grade

pharmaceutical primary standard

grade

analytical standard

grade

primary reference standard

grade

certified reference material, TraceCERT®

application(s)

pharmaceutical (small molecule)

application(s)

cleaning products
cosmetics
food and beverages
personal care

application(s)

food and beverages

application(s)

food and beverages

format

neat

format

neat

format

neat

format

neat

API family

resveratrol

API family

-

API family

-

API family

-

storage temp.

−20°C

storage temp.

−20°C

storage temp.

2-8°C

storage temp.

−20°C

Application

Selective inhibitor of COX−1.

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

comparable product

Product No.
Description
Pricing

pictograms

Exclamation mark
GHS07

signalword

Warning

hcodes

H319

Hazard Classifications

Eye Irrit. 2

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

>392.0 °F - closed cup - (External MSDS)

flash_point_c

> 200.0 °C - closed cup - (External MSDS)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Mary Ann Augustin et al.
Annals of the New York Academy of Sciences, 1290, 107-112 (2013-07-17)
There has been interest in the use of trans-resveratrol as a natural preventative agent for improving health and alleviating a range of diseases. However, resveratrol has low bioavailability, and this has been associated with its poor water solubility, its low
Silvie Timmers et al.
Annals of the New York Academy of Sciences, 1290, 83-89 (2013-07-17)
The number of people suffering from metabolic disorders is dramatically increasing worldwide. The need for new therapeutic strategies to combat this growing epidemic of metabolic diseases is therefore also increasing. In 2003, resveratrol was discovered to be a small molecule
Agneta Oskarsson et al.
The Prostate, 74(8), 839-851 (2014-03-13)
Resveratrol (RSV) and resveratrol analogs have a potential use in prostate cancer chemoprevention due to effects on for example, cell growth, apoptosis, angiogenesis, and metastasis. However, inhibition of CYP17A1, a key enzyme in the androgen biosynthesis and a target for
Morten Møller Poulsen et al.
Annals of the New York Academy of Sciences, 1290, 74-82 (2013-07-17)
In the search for novel preventive and therapeutic modalities in the management of metabolic diseases and obesity, resveratrol has attracted great attention over the past decades. Preclinical trials suggest that resveratrol mimics the metabolic effects of calorie restriction (CR) via
Dominique Delmas et al.
Annals of the New York Academy of Sciences, 1290, 90-97 (2013-07-17)
The preventive effects of the phytoalexin trans-resveratrol toward cancer have been largely described at the cellular and molecular levels in both in vivo and in vitro models; however, its primary targets are still poorly identified. In this review, we show
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service